- About Us
- Annual Meeting
- Notice Board
CCNP 42nd Annual Meeting
June 12 to 15, 2019
This is the first Call for Poster Abstracts for the Canadian College of Neuropsychopharmacology 2019 meeting to be held in the heart of downtown Montréal at Thomson House (McGill University), June 12th-15th, 2019.
Poster submissions should include: (1) Title, (2) List of authors with affiliations, (3) Abstract: introduction, methods, results and conclusions (maximum 300 words). The local organizing committee encourages submissions with a translational component and a mix of junior and senior researchers. We encourage individuals from equity seeking groups such as women, racialized/visible minorities, Aboriginal peoples, persons with a disability and others who reflect the diversity of Canadian society to be included as presenters.
Registration is available at the meeting. Only cash and cheques accepted.
We look forward to seeing you in Montréal!
In keeping with CMA guidelines, program content and selection of speakers are the responsibility of the planning committee. Support is directed toward the costs and not to individual speakers through an unrestricted educational grant.
The Canadian College of Neuropsychopharmacology appreciates the support of the following sponsors:
|GOLD LEVEL SPONSORSHIP|
|SILVER LEVEL SPONSORSHIP|
|BRONZE LEVEL SPONSORSHIP|
|The Canadian College of Neuropsychopharmacology appreciates the ongoing support of Pfizer Canada Inc. for the Heinz Lehman, Innovations in Neuropsychopharmacology and the Young Investigator Award.|
The CAN and SfN have also released their statements about the immigration executive order on their websites: